FDA Guidance Regarding Emergency Use Authorizations and the Use of Investigational Products During the Pandemic Harvey M. Arbit, PharmD, MBA, President and CEO of Arbit Consulting, a firm that provides drug and medical device regulatory strategy and support for industry, academia, and investigator-initiated clinical research. He is adjunct professor at the University of Minnesota, College of Pharmacy, and adjunct professor at Albany College of Pharmacy and Health Sciences AND Wrenda M. Teeple, PharmD, Chief Clinical Officer and Director of Regulatory affairs, Arbit Consulting; Clinical Pharmacist, Regions Hospital. She is Adjunct Professor, St. Catherine's University, Henrietta Schmoll School of Health, and Adjunct Assistant Professor, Albany College of Pharmacy and Health Sciences.

Engaging Non-English Speaking Participants and Families Remotely Idolly F. Oliva, MBA, Director Language Services, M Health Fairview